• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Morphosys Ag ADR (NQ: MOR )

    17.41 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 17.41
    Bid (Size) 17.17 (20)
    Ask (Size) 17.70 (1)
    Prev. Close 17.41
    Today's Range 17.41 - 17.41
    52wk Range 4.185 - 18.30
    Shares Outstanding 32,890,046
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    MOR Stock Earnings: MorphoSys Misses EPS, Misses Revenue for Q1 2024
    MOR stock results show that MorphoSys missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    MorphoSys AG Reports First Quarter 2024 Financial Results
    From MorphoSys AG
    Via Business Wire

    Performance

    YTD
    +80.60%
    +80.60%
    1 Month
    -3.87%
    -3.87%
    3 Month
    +59.87%
    +59.87%
    6 Month
    +118.44%
    +118.44%
    1 Year
    +225.42%
    +225.42%

    More News

    Read More
    MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, Pelabresib
    Via Benzinga
    Exposures Product Safety
    MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
    Via ACCESSWIRE
    Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
    Via Benzinga
    MorphoSys: Q4 Earnings Insights
    Via Benzinga
    Earnings Outlook For MorphoSys
    Via Benzinga
    Invitation to MorphoSys' Full Year Results 2023 Conference Call on March 14, 2024
    Via ACCESSWIRE
    Dow Plummets on Rising Bond Yields, MCD Earnings
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    MorphoSys’ Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
    From MorphoSys AG
    Via Business Wire
    MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
    Via ACCESSWIRE
    MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
    Via ACCESSWIRE
    MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    From MorphoSys AG
    Via Business Wire
    MorphoSys AG (NASDAQ: MOR) Near the Top of Equities by Percentage Gain on 2/5
    Via Investor Brand Network
    Earnings Scheduled For March 13, 2024
    Via Benzinga
    5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
    Via Talk Markets
    3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
    Via InvestorPlace
    Exit Now! 3 Biotech Stocks to Sell in February 2024
    Via InvestorPlace
    Novartis Agrees To Acquire German Blood Cancer-Drug Developer MorphoSys For €2.7B
    Via Benzinga
    Biotech Stock MorphoSys Catapults 56% As Novartis Agrees To Buy It For $2.9 Billion
    Via Investor's Business Daily
    Why Is MorphoSys (MOR) Stock Up 50% Today?
    Via InvestorPlace
    Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    MorphoSys Stock Soars After Report Says Novartis To Acquire Cancer-Drug Developer
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value
    Via ACCESSWIRE
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.